Christian S. Schade

Christian S. Schade

DirectoratIntegra Lifesciences Holdings· In proxies 2023–2025

Christian S. Schade sits on 5 public boards.

Boards1

  • Integra Lifesciences HoldingsDirector · 19 yr on the boardIndependentAudit (Chair), Finance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Integra Lifesciences HoldingsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -78%
  2. From July 2023 to January 2025, Mr. Schade served on the board of Omega Therapeutics, Inc. (Nasdaq: OMGA), where he served as a member of its compensationPublic company
    • Director? – PresentNo stock prices for these years
  3. Mr. Schade currently serves as the chair of the board of Omega Therapeutics (Nasdaq: OMGA). From 2016 to August 2023, Mr. Schade served on the board of Aprea Therapeutics, Inc. (Nasdaq: APRE). Other ProfessionalPublic company
    • Director? – PresentNo stock prices for these years
  4. Omega Therapeutics, Inc.Public company · 2 yr
    • Director2023 – 2025 · 2 yrNo stock prices for these years
  5. Other Public Company DirectorshipsPublic company · 2 yr
    • Director2023 – 2025 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?